NASDAQ:FWP - Forward Pharma A/S
$1.41
 $-0.03
-2.29%
1:55PM EDT
2019-02-15
Forward Pharma A/S is a clinical-stage biopharmaceutical company. The Company is engaged in the development of FP187, a formulation of dimethyl fumarate (DMF) for the treatment of several inflammatory and neurological indications, including multiple sclerosis (MS). The Company's clinical candidate, FP187, is under development for the treatment of relapsing remitting MS (RRMS) and other immune disorders, such as psoriasis. The Company's DMF formulation, FP187, employs over two methods, which improves the release of DMF by reducing the peaks of monomethyl fumarate (MMF) in the bloodstream while maintaining overall DMF exposure levels, which, in turn, controls DMF's side effects. The Company has conducted a pre-clinical program and has completed several Phase I and Phase II clinical trials for the product FP187. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  FWP     avg for
industry  
  avg for
sector  
42 stocks weight:  16. 65   0. 00   0. 00  
42 stocks rank:  3. 76 K 1. 86 K 1. 09 K
# analyst opinions:  1. 00   14. 92   14. 43  

quick ratio:  17. 18   5. 37   1. 81  
current ratio:  17. 23   5. 69   2. 19  

ex-dividend date:     2017-09-11
target price low:  3. 70   88. 97   117. 82  
target price avg:  3. 70   115. 19   141. 96  
target price high:  3. 70   143. 40   163. 16  
1-yr high:  4. 09   124. 30   142. 77  
last close:  1. 44   101. 85   127. 84  
50-day avg:  1. 05   98. 27   122. 46  
200-day avg:  2. 07   99. 72   122. 70  
1-yr low:  0. 71   78. 19   100. 16  
volume:  16. 32 K 2. 38 M 4. 64 M
50-day avg volume:  21. 76 K 3. 31 M 4. 94 M
200-day avg volume:  69. 49 K 3. 23 M 4. 28 M

1-day return:  0. 70 % 0. 22 % 0. 48 %
this week return:  -5. 88 % 1. 77 % 2. 01 %
12-wk return:  19. 01 % 6. 56 % 3. 33 %
52-wk return:  -55. 35 % -2. 23 % 14. 35 %

enterprise value (EV):  -20. 13 M 55. 17 B 104. 51 B
market cap:  68. 18 M 49. 01 B 96. 46 B
EBITDA:  -28. 22 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  0. 71   -91. 79   2. 29  
total debt:  0. 00   13. 73 B 16. 57 B
net income (common):  -29. 41 M 2. 37 B 3. 58 B

shares outstanding:  47. 35 M 607. 99 M 1. 22 B
shares:  3. 67 M 605. 53 M 1. 15 B
shares short:  19. 67 K 11. 62 M 12. 55 M
shares short prior month:  37. 71 K 11. 95 M 13. 44 M
short ratio:  1. 34   4. 82   3. 10  
total cash/share:  1. 89   12. 02   11. 46  
total cash:  89. 26 M 7. 41 B 7. 37 B
free cash flow:  -269. 23 M 95. 99 M 2. 04 B
operating cash flow:  -281. 22 M 164. 74 M 3. 04 B

book value:  1. 80   14. 43   28. 26  
price/book:  0. 80   -1. 57   -2. 97  
gross profits:  -25. 00 M 8. 28 B 18. 09 B
operating margins:  0. 00 % -458. 01 % -642. 83 %
EBITDA margins:  0. 00 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  0. 00 % 49. 33 % 54. 53 %

1-yr max volatility:  85. 91 % --- ---
1-yr mean volatility:  -0. 04 % 0. 01 % 0. 06 %

1-yr EPS:  -0. 62   3. 03   4. 09  
forward EPS:  -0. 09   4. 33   6. 99  
P/E:  -2. 32   6. 11   26. 91  
forward P/E:  -15. 89   8. 38   10. 48  
PE/G:  0. 72   0. 37   5. 61  
growth:  -3. 23 % 683. 72 % 104. 79 %
earnings high:  -0. 00   1. 27   1. 66  
earnings avg:  -0. 00   1. 01   1. 53  
earnings low:  -0. 00   0. 76   1. 40  
revenue high:  -0. 00   2. 86 B 11. 19 B
revenue avg:  -0. 00   2. 78 B 10. 84 B
revenue low:  -0. 00   2. 67 B 10. 64 B
return on assets:  -2. 32 % -3. 27 % 3. 81 %
return on equity:  -4. 67 % 107. 48 % 27. 82 %

beta (1yr vs S&P500):  0. 66   1. 21   0. 93  
sharpe (1yr):  -0. 07   0. 06   0. 98  

held % insiders:  0. 00 % 6. 46 % 3. 21 %
held % institutions:  18. 53 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : FWP
.    + 0.579 =         0.579 :: INITIAL WEIGHT
.  + 845.066 =       845.645 :: inverse volume-to-price addition
.  + 262.121 =      1107.766 :: spline projection addition
.  - 211.379 =       896.387 :: poor performance penalty
.    x 0.657 =       589.373 :: one-year gains+dividend factor
.     x 9.08 =       5351.31 :: 13 weeks' performance factor
.    x 1.492 =      7986.771 :: industry recommendation factor
.      x 1.0 =      7984.918 :: return on assets factor
.      x 1.0 =      7981.189 :: return on equity factor
.    x 3.026 =     24152.859 :: current ratio factor
.     x 1.03 =     24888.095 :: quick ratio factor
.    x 1.321 =     32888.736 :: short ratio factor
.    x 2.008 =     66040.582 :: price-to-book factor
.    x 5.574 =    368108.159 :: EBITDA multiple factor
.    x 1.389 =    511436.963 :: 5-day avg > 50-day avg
.    x 2.162 =   1105928.605 :: P/E weight
.    x 1.087 =   1201765.741 :: PE/G factor
.    x 1.698 =   2040597.085 :: beta factor
.    x 0.069 =    141799.704 :: sharpe factor
.    x 2.451 =    347502.167 :: target low factor
.    x 1.418 =    492616.141 :: target mean factor
.    x 1.125 =    554329.844 :: target high factor
.    x 1.066 =    590700.981 :: industry 12-weeks return
.    x 0.875 =    516569.625 :: "drift" penalty 2 days ago
.    x 0.999 =    516023.434 :: overall "drift" factor
.    x 0.141 =     72712.378 :: largest single-day jump factor
.    x 0.064 =      4619.592 :: low price factor
.      x 1.0 =      4619.902 :: factor hist industry gain for week 06
.   cubeRoot =        16.655 :: reduced for readability
.                     16.655 :: FINAL WEIGHT for NASDAQ:FWP


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org